HCM
EPZM

Highbridge Capital Management’s Epizyme, Inc EPZM Stock Holding History

Highbridge Capital Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-48,867
Closed -$481K – 1697
2016
Q3 		$481K Buy
+48,867
New +$446K 0.01% 800
2016
Q2 		– Sell
-13,808
Closed -$167K – 1855
2016
Q1 		$167K Buy
+13,808
New +$140K ﹤0.01% 1368
2015
Q2 		– Sell
-15,997
Closed -$300K – 1747
2015
Q1 		$300K Buy
+15,997
New +$330K ﹤0.01% 1128

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Highbridge Capital Management's EPZM Position: Q4 2016 in Review

Highbridge Capital Management sold out of Epizyme, Inc (EPZM) in Q4 2016, closing a stake of 48,867 shares — an estimated $481K sold.

Highbridge Capital Management first reported a position in EPZM in Q1 2015 and held it in 3 quarters. The position peaked at $481K in Q3 2016. 94 funds tracked by Wall St. Rank hold EPZM as of Q4 2016.

  • Highbridge Capital Management reported no remaining Epizyme, Inc position as of Q4 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 48,867 Epizyme, Inc shares in Q4 2016, an estimated $481K.
  • Highbridge Capital Management first reported a position in Epizyme, Inc in Q1 2015 and held it in 3 quarters.
  • Highbridge Capital Management's Epizyme, Inc position peaked at $481K in Q3 2016.
  • 94 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2016.

Based on Highbridge Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.